|
(Health-NewsWire.Net, April 29, 2015 ) GlobalData’s clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2015″ provides data on the Sezary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sezary Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sezary Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Complete report on H1 2015 pipeline review of “Sezary Syndrome” addiction with 42 market data tables and 20 figures, spread across 91 pages is available at http://www.rnrmarketresearch.com/sezary-syndrome-global-clinical-trials-review-h1-2015-market-report.html . (This is a premium report price at US$2500 for a single user PDF license)
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope:
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=329890 .
Reasons to Buy:
• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents:
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Sezary Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Sezary Syndrome to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
More reports on Clinical Trial :
Hematological Tumor Global Clinical Trials Review, H1, 2015
GlobalData’s clinical trial report, “Hematological Tumor Global Clinical Trials Review, H1, 2015″ provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematological Tumor.
Complete report is available at http://www.rnrmarketresearch.com/hematological-tumor-global-clinical-trials-review-h1-2015-market-report.html .
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
